The stock, sold at an average price of 5.94 levs apiece on the Bulgarian Stock Exchange, represents 0.40% of Sopharma’s equity capital, the company said in a bourse filing on Wednesday.
The own shares held by Sopharma following the deal amount to 13,377,998, equal to 7.47% of the company's equity capital.
Earlier this week, Sopharma said it sold 68,500 shares for 407,940 levs in total.
Last August, Sopharma's shareholders endorsed a proposal for a share repurchase programme, which would run for up to 18 months and target up to 3% of the company's equity capital per year.
As of 1045 CEST on Thursday, shares in Sopharma traded 0.34% higher at 5.94 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)